Neurofibromatosis‐ and schwannomatosis‐associated tumors: Approaches to genetic testing and counseling considerations
American Journal of Medical Genetics Part A · 2023
DOI: 10.1002/ajmg.a.63346 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Medical Genetics Part A, 2023. Verfasst von Allison Goetsch Weisman und 5 weiteren Autor:innen. Beteiligte Einrichtung: Division of Genetics, Genomics and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Neurofibromatosis 2, Neurofibromatosis 1, Neurilemmoma, Neurofibromatoses. Die Arbeit wurde bisher 25-mal zitiert (Crossref) und nennt 130 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Neurofibromatosis (NF) and schwannomatosis (SWN) are genetic conditions characterized by the risk of developing nervous system tumors. Recently revised diagnostic criteria include the addition of genetic testing to confirm a pathogenic variant, as well as to detect the presence of mosaicism. Therefore, the use and interpretation of both germline and tumor‐based testing have increasing importance in the diagnostic approach, treatment decisions, and risk stratification of these conditions. This focused review discusses approaches to genetic testing of NF‐ and SWN‐related tumor types, which are somewhat rare and perhaps lesser known to non‐specialized clinicians. These include gastrointestinal stromal tumors, breast cancer, plexiform neurofibromas with or without transformation to malignant peripheral nerve sheath tumors, gliomas, and schwannomas, and emphasizes the need for inclusion of genetic providers in patient care and appropriate pre‐ and post‐test education, genetic counseling, and focused evaluation by a medical geneticist or other healthcare provider familiar with clinical manifestations of these disorders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Genetics, Genomics and Metabolism, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
- Division of Oncology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, Illinois, USA.
- Department of Pediatrics, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
- Children's Tumor Foundation, New York, New York, USA.
- Tempus Labs, Inc., Chicago, Illinois, USA.
ORCID-Profile: Allison Goetsch Weisman, Alicia Gomes
Zitieren
APA
Goetsch Weisman, A., Weiss McQuaid, S., Radtke, H. B., Stoll, J., Brown, B., & Gomes, A. (2023). Neurofibromatosis‐ and schwannomatosis‐associated tumors: Approaches to genetic testing and counseling considerations. American Journal of Medical Genetics Part A. https://doi.org/10.1002/ajmg.a.63346
Vancouver
Goetsch Weisman A, Weiss McQuaid S, Radtke HB, Stoll J, Brown B, Gomes A. Neurofibromatosis‐ and schwannomatosis‐associated tumors: Approaches to genetic testing and counseling considerations. American Journal of Medical Genetics Part A. 2023. doi:10.1002/ajmg.a.63346
BibTeX
@article{GoetschWeisman2023,
author = {Goetsch Weisman, Allison and Weiss McQuaid, Shelly and Radtke, Heather B and Stoll, Jessica and Brown, Bryce and Gomes, Alicia},
title = {Neurofibromatosis‐ and schwannomatosis‐associated tumors: Approaches to genetic testing and counseling considerations},
journal = {American Journal of Medical Genetics Part A},
year = {2023},
doi = {10.1002/ajmg.a.63346}
}
EUVIMED